Pankreas Yetmezliği
Özet
Pankreas yetmezliği, özellikle sindirim için gerekli olan enzimlerin lümen içerisindeki aktivitesinin azalmasıyla karakterize, yaşam kalitesini ciddi oranda düşüren klinik bir durumdur. Yetişkinlerde en yaygın etiyolojik neden kronik pankreatit iken, çocuklarda kistik fibroz ön plana çıkmaktadır. Hastalık; steatore, karın ağrısı, kilo kaybı ve malnütrisyon gibi semptomlarla kendini gösterir ve tedavi edilmediğinde osteoporoz veya kardiyovasküler olaylar gibi ciddi komplikasyonlara yol açabilir. Tanı sürecinde fekal elastaz-1 testi en yaygın kullanılan yöntemdir; ancak 72 saatlik fekal yağ ölçümü (CFA) altın standart kabul edilmektedir. Tedavinin temelini, sindirim sürecini normale döndürmeyi amaçlayan pankreatik enzim replasman tedavisi (PERT) ve yaşam tarzı değişiklikleri oluşturur. Ayrıca pankreatik psödokistler ve kronik ağrı yönetimi, hastalığın prognozu açısından kritik öneme sahiptir. Erken teşhis ve uygun enzim desteği, morbidite ve mortalite riskini azaltarak hastaların yaşam süresini ve kalitesini bağımsız bir şekilde iyileştirmektedir.
Pancreatic insufficiency is a clinical condition characterized by the decreased activity of enzymes necessary for digestion within the intestinal lumen, significantly impairing the quality of life. While chronic pancreatitis is the most common etiological cause in adults, cystic fibrosis is more prevalent in children. The disease manifests with symptoms such as steatorrhea, abdominal pain, weight loss, and malnutrition, and if left untreated, it can lead to serious complications such as osteoporosis or cardiovascular events. In the diagnostic process, the fecal elastase-1 test is the most widely used method, although the 72-hour fecal fat measurement (CFA) is considered the gold standard. The cornerstone of treatment is pancreatic enzyme replacement therapy (PERT), which aims to normalize the digestive process, alongside lifestyle modifications. Furthermore, the management of pancreatic pseudocysts and chronic pain is critical for the prognosis of the disease. Early diagnosis and appropriate enzyme supplementation independently improve the lifespan and quality of life by reducing the risk of morbidity and mortality.
Referanslar
Duggan SN. Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis. Proc Nutr Soc. 2017;76:484–494.
Benjamin O, Lappin SL. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jun 26, 2021. Chronic Pancreatitis.
Singh VK, Haupt ME, Geller DE, et al. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23:7059-7076.
Pham A, Forsmark C. Chronic pancreatitis: review and update of etiology, risk factors, and management. F1000Res. 2018;7:F1000 Faculty Rev-607.
Alkaade S, Vareedayah AA. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities. Am J Manag Care. 2017;23:S203-S209.
Singh VK, Schwarzenberg SJ. Pancreatic insufficiency in Cystic Fibrosis. J Cyst Fibros. 2017;16:S70-S78.
Vujasinovic M, Tepes B, Volfand J, et al. Exocrine pancreatic insufficiency, MRI of the pancreas and serum nutritional markers in patients with coeliac disease. Postgrad Med J. 2015;91:497-500.
Fousekis FS, Theopistos VI, Katsanos KH, Christodoulou DK. Pancreatic Involvement in Inflammatory Bowel Disease: A Review. J Clin Med Res. 2018;10:743-751.
Vujasinovic M, Valente R, Thorell A, et al. Pancreatic Exocrine Insufficiency after Bariatric Surgery. Nutrients. 2017;9:1241.
Martin TC, Scourfield A, Rockwood N, et al. Pancreatic insufficiency in patients with HIV infection: role of didanosine questioned. HIV Med. 2013;14:161-6.
Capurso G, Traini M, Piciucchi M, et al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129-139.
Machicado JD, Chari ST, Timmons L, et al. A population-based evaluation of the natural history of chronic pancreatitis. Pancreatology. 2018;18:39-45.
Huang W, de la Iglesia-García D, Baston-Rey I, et al. Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis. Dig Dis Sci. 2019;64:1985-2005.
Hollemans RA, Hallensleben NDL, Mager DJ, et al; Dutch Pancreatitis Study Group. Pancreatic exocrine insufficiency following acute pancreatitis: systematic review and study level meta-analysis. Pancreatology. 2018;18:253–262.
Søfteland E, Poulsen JL, Starup-Linde J, et al. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. Eur J Intern Med. 2019;68:18-22.
Alexandre-Heymann L, Lemoine AY, Nakib S, et al. Nutritional markers in patients with diabetes and pancreatic exocrine failure. Acta Diabetol. 2019;56:651-658.
Othman MO, Harb D, Barkin JA. Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician. Int J Clin Pract. 2018;72:e13066.
Xia T, Chai X, Shen J. Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss. PLoS One. 2017;12:e0187804.
Campbell J, Sanders D, Francis K, et al. Should we investigate gastroenterology patients for pancreatic exocrine insufficiency? A dual centre UK study. J Gastrointestin Liver Dis 2016; 25: 303-309.
Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5:153-199.
Cooney AL, McCray PB Jr, Sinn PL. Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward. Genes (Basel). 2018;9:538.
Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC Med. 2017;15:29.
Nousia-Arvanitakis S, Fotoulaki M, Tendzidou K, et al. Subclinical exocrine pancreatic dysfunction resulting from decreased cholecystokinin secretion in the presence of intestinal villous atrophy. J Pediatr Gastroenterol Nutr. 2006;43:307-12.
Vujasinovic M, Valente R, Del Chiaro M, et al. Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Nutrients. 2017;9:183.
Bartel MJ, Asbun H, Stauffer J, et al. Pancreatic exocrine insufficiency in pancreatic cancer: A review of the literature. Dig Liver Dis. 2015;47:1013-1020.
Partelli S, Frulloni L, Minniti C, et al. Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. Dig Liver Dis. 2012;44:945-951.
Sabater L, Ausania F, Bakker OJ, et al. Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Ann Surg. 2016;264:949-958.
Hayden MR, Patel K, Habibi J, et al. Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities. J Cardiometab Syndr. 2008;3:234-243.
Knop FK. Incretin hormones and beta cell function in chronic pancreatitis. Dan Med Bull. 2010;57:B4163.
Larger E, Philippe MF, Barbot-Trystram L, et al. Pancreatic exocrine function in patients with diabetes. Diabet Med. 2012;29:1047-1054.
Bertelli E, Bendayan M. Association between endocrine pancreas and ductal system. More than an epiphenomenon of endocrine differentiation and development?. J Histochem Cytochem. 2005;53:1071-1086.
Perbtani Y, Forsmark CE. Update on the diagnosis and management of exocrine pancreatic insufficiency. F1000Res. 2019;8.
Domínguez Muñoz JE. Diagnosis of chronic pancreatitis: functional testing. Best Pract Res Clin Gastroenterol. 2010;24:233–241.
Van de Vijver E, Desager K, Mulberg AE, et al. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. J Pediatr Gastroenterol Nutr. 2011;53:61–64.
Beharry S, Ellis L, Corey M, Marcon M, Durie P. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr. 2002;141:84–90.
Antonini F, Crippa S, Falconi M, et al. Pancreatic enzyme replacement therapy after gastric resection: an update. Dig Liver Dis. 2018;50(1):1–5.
Ritz MA, Fraser RJ, Di Matteo AC, et al. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis. J Gastroenterol Hepatol. 2004;19:448–453.
Borowitz D, Konstan MW, O'Rourke A, et al. Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis. J Pediatr Pharmacol Ther. 2007;12:47-52.
Mee AS, Girdwood AH, Walker E, et al. Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis. Gut. 1985;26:1257–1262.
Albashir S, Bronner MP, Parsi MA, et al. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am J Gastroenterol. 2010;105:2498–2503.
Cappeliez O, Delhaye M, Devière J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with Mr pancreatography after secretin stimulation. Radiology. 2000;215:358–364.
Nikfarjam M, Wilson JS, Smith RC., Australasian Pancreatic Club Pancreatic Enzyme Replacement Therapy Guidelines Working Group. Diagnosis and management of pancreatic exocrine insufficiency. Med J Aust. 2017;207:161-165.
Bartel MJ, Asbun H, Stauffer J, et al. Pancreatic exocrine insufficiency in pancreatic cancer: a review of the literature. Dig Liver Dis. 2015;47:1013-1020.
de la Iglesia-García D, Huang W, Szatmary P, et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut. 2017;66:1354-1355.
Elborn JS. Cystic fibrosis. Lancet 2016; 388:2519-2531.
Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol. 2013;19:7258-66.
Roberts KJ, Bannister CA, Schrem H. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study. Pancreatology. 2019;19:114-121.
Ghodeif AO, Azer SA. Pancreatic Insufficiency. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 28, 2021.
Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5:153-199.
Demir IE, Friess H, Ceyhan GO. Neural plasticity in pancreatitis and pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2015;12:649-659.
Drewes AM, Krarup AL, Detlefsen S, et al. Pain in chronic pancreatitis: the role of neuropathic pain mechanisms. Gut. 2008;57:1616-1627.
Poulsen JL, Olesen SS, Malver LP, et al. Pain and chronic pancreatitis: a complex interplay of multiple mechanisms. World J Gastroenterol. 2013;19:7282-7291.
Zhu Y, Colak T, Shenoy M, et al. Nerve growth factor modulates TRPV1 expression and function and mediates pain in chronic pancreatitis. Gastroenterology. 2011;141:370-377.
Lieb JG 2nd, Forsmark CE. Review article: pain and chronic pancreatitis. Aliment Pharmacol Ther. 2009;29:706-719.
Talukdar R, Murthy HV, Reddy DN. Role of methionine containing antioxidant combination in the management of pain in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology. 2015;15:136-144.
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102-11.
Pan G, Wan MH, Xie KL, et al. Classification and Management of Pancreatic Pseudocysts. Medicine (Baltimore) 2015;94:e960.
Andalib I, Dawod E, Kahaleh M. Modern Management of Pancreatic Fluid Collections. J Clin Gastroenterol 2018;52:97-104.
Habashi S, Draganov PV. Pancreatic pseudocyst. World J Gastroenterol 2009;15:38-47.
Dhaka N, Samanta J, Kochhar S, et al. Pancreatic fluid collections: What is the ideal imaging technique? World J Gastroenterol 2015;21:13403-10.
